Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
P.7NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
P.2 (Zeta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.33NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
N.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.499NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
N.9NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.212NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
JN.1.61NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.16.6NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-17723.5South Korea
JN.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
JN.1.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.86NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.41.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GS.4.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
JF.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EG.5.1.13NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
JG.3.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.16.28NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBBNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
JN.1.13NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.16.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.5.62NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GW.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
DV.6.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FK.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
HF.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
HK.31NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
HG.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EG.4.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.9.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FL.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FY.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XDBNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GA.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.5.35NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GM.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FL.3.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.5.44NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FU.3.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FV.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GJ.1.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.16.7NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-4273.88South Korea
XBB.1.22.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FE.1.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBL.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.5.56NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.16.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EG.1.8NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.5.49NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBL.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used